The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
The 119th Congress and the Trump Administration have before them significant challenges for long-term healthcare reforms. | To help prevent painful injuries and costly hospitalizations, and reduce ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
An expanding prohibition on third-party financial guarantees could lead to more nursing home using lawsuits to collect unpaid ...
The Centers for Medicare & Medicaid Services (CMS) finalized significant updates to the Medicare 60-Day Rule, which governs ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...
The Centers for Medicare & Medicaid Services (CMS) recently announced two significant updates to Workers’ Compensation ...